S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
NYSE:PKI

Revvity (PKI) Price Target & Analyst Ratings

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$115.24
▼
$137.11
52-Week Range
N/A
Volume
1.63 million shs
Average Volume
851,117 shs
Market Capitalization
$14.57 billion
P/E Ratio
15.01
Dividend Yield
0.24%
Price Target
$153.29
ProfileAnalyst RatingsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Revvity Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$153.29
High Prediction$165.00
Average Prediction$153.29
Low Prediction$125.00
TypeCurrent
8/14/22 to 8/14/23		1 Month Ago
7/15/22 to 7/15/23		3 Months Ago
5/16/22 to 5/16/23		1 Year Ago
8/14/21 to 8/14/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$153.29$156.78$158.60$161.13
Predicted UpsideN/A15.01% Upside16.66% Upside1.62% Upside
Get Revvity Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PKI and its competitors with MarketBeat's FREE daily newsletter.


PKI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PKI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Revvity Stock vs. The Competition

TypeRevvityMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.65
2.48
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside3,395.69% Upside324.28% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/15/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$170.00 ➝ $160.00+37.58%
5/12/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$145.00 ➝ $135.00+14.05%
5/12/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$182.00 ➝ $165.00+39.39%
5/12/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$140.00 ➝ $125.00+5.60%
2/15/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingNeutral$160.00+18.81%
12/6/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeMarket Perform ➝ Outperform$164.00+19.76%
12/6/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeMarket Perform ➝ Outperform$192.00 ➝ $164.00+19.76%
(Data available from 8/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












PKI Price Target - Frequently Asked Questions

What is Revvity's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Revvity stock is Moderate Buy based on the current 3 hold ratings and 4 buy ratings for PKI. The average twelve-month price prediction for Revvity is $153.29 with a high price target of $165.00 and a low price target of $125.00. Learn more on PKI's analyst rating history.

Do Wall Street analysts like Revvity more than its competitors?

Analysts like Revvity less than other Medical companies. The consensus rating score for Revvity is 2.57 while the average consensus rating score for medical companies is 2.65. Learn more on how PKI compares to other companies.

Does Revvity's stock price have much upside?

According to analysts, Revvity's stock has a predicted upside of 15.56% based on their 12-month price targets.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:PKI) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -